Gerson Shigeaki Hamada
Research Subjects
Research Interests
Gerson Shigeaki Hamada has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Fábio Martins Laginha
Department of Breast Surgery, Hospital Pérola Byington, São Paulo, Brazil
2 shared publications - Ines Nobuko Nishimoto
Department of Head and Neck Surgery and Otorhinolaryngology, Cancer Hospital AC Camargo, 01509-010 São Paulo, Brazil
2 shared publications - Juvenal Mottola Junior
Department of Breast Surgery, Hospital Pérola Byington, São Paulo, Brazil
2 shared publications - Motoki Iwasaki
Division of Epidemiology, National Cancer Center Institute for Cancer Control, Tokyo, Japan
2 shared publications - Shoichiro Tsugane
Division of Cohort Research National Cancer Center Institute for Cancer Control Tokyo Japan
2 shared publications - Enbo Ma
Epidemiology and Prevention Division, Research Center for Cancer Prevention and Screening, National Cancer Center, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045, Japan
1 shared publication
Latest Publications
- Open Access
- 16 February 2011
- Published by Springer Nature in BMC Medicine
- Vol. 9 (1) , 16
Comparison of postmenopausal endogenous sex hormones among Japanese, Japanese Brazilians, and non-Japanese Brazilians
Differences in sex hormone levels among populations might contribute to the variation in breast cancer incidence across countries. Previous studies have shown higher breast cancer incidence and mortality among Japanese Brazilians than among Japanese. To clarify the difference in hormone levels among populations, we compared postmenopausal endogenous sex hormone levels among Japanese living in Japan, Japanese Brazilians living in the state of São Paulo, and non-Japanese Brazilians living in the state of São Paulo. A cross-sectional study was conducted using a control group of case-control studies in Nagano, Japan, and São Paulo, Brazil. Participants were postmenopausal women older than 55 years of age who provided blood samples. We measured estradiol, estrone, androstenedione, dehydroepiandrosterone sulfate (DHEAS), testosterone and free testosterone by radioimmunoassay; bioavailable estradiol by the ammonium sulfate precipitation method; and sex hormone-binding globulin (SHBG) by immunoradiometric assay. A total of 363 women were included for the present analyses, comprising 185 Japanese, 44 Japanese Brazilians and 134 non-Japanese Brazilians. Japanese Brazilians had significantly higher levels of estradiol, bioavailable estradiol, estrone, testosterone and free testosterone levels, and lower SHBG levels, than Japanese. Japanese Brazilians also had significantly higher levels of bioavailable estradiol, estrone and DHEAS and lower levels of SHBG and androstenedione than non-Japanese Brazilians. Levels of estradiol, testosterone and free testosterone, however, did not differ between Japanese Brazilians and non-Japanese Brazilians. These differences were observed even after adjustment for known breast cancer risk factors. We also found an increase in estrogen and androgen levels with increasing body mass index, but no association for most of the other known risk factors. We found higher levels of estrogens and androgens in Japanese Brazilians than in Japanese and levels similar to or higher than in non-Japanese Brazilians. Our findings may help explain the increase in the incidence and mortality rate of breast cancer among Japanese Brazilians.
- 16 February 2011
- Published by Springer Nature in BMC Medicine
- Vol. 9 (1) , 16
Open AccessComparison of postmenopausal endogenous sex hormones among Japanese, Japanese Brazilians, and non-Japanese Brazilians
Differences in sex hormone levels among populations might contribute to the variation in breast cancer incidence across countries. Previous studies have shown higher breast cancer incidence and mortality among Japanese Brazilians than among Japanese. To clarify the difference in hormone levels among populations, we compared postmenopausal endogenous sex hormone levels among Japanese living in Japan, Japanese Brazilians living in the state of São Paulo, and non-Japanese Brazilians living in the state of São Paulo. A cross-sectional study was conducted using a control group of case-control studies in Nagano, Japan, and São Paulo, Brazil. Participants were postmenopausal women older than 55 years of age who provided blood samples. We measured estradiol, estrone, androstenedione, dehydroepiandrosterone sulfate (DHEAS), testosterone and free testosterone by radioimmunoassay; bioavailable estradiol by the ammonium sulfate precipitation method; and sex hormone-binding globulin (SHBG) by immunoradiometric assay. A total of 363 women were included for the present analyses, comprising 185 Japanese, 44 Japanese Brazilians and 134 non-Japanese Brazilians. Japanese Brazilians had significantly higher levels of estradiol, bioavailable estradiol, estrone, testosterone and free testosterone levels, and lower SHBG levels, than Japanese. Japanese Brazilians also had significantly higher levels of bioavailable estradiol, estrone and DHEAS and lower levels of SHBG and androstenedione than non-Japanese Brazilians. Levels of estradiol, testosterone and free testosterone, however, did not differ between Japanese Brazilians and non-Japanese Brazilians. These differences were observed even after adjustment for known breast cancer risk factors. We also found an increase in estrogen and androgen levels with increasing body mass index, but no association for most of the other known risk factors. We found higher levels of estrogens and androgens in Japanese Brazilians than in Japanese and levels similar to or higher than in non-Japanese Brazilians. Our findings may help explain the increase in the incidence and mortality rate of breast cancer among Japanese Brazilians.
- Open Access
- 24 April 2009
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 122
Dietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women
Background: Several studies have determined that dietary intake of B vitamins may be associated with breast cancer risk as a result of interactions between5,10-methylenetetrahydrofolate reductase (MTHFR)andmethionine synthase(MTR) in the one-carbon metabolism pathway. However, the association between B vitamin intake and breast cancer risk in Brazilian women in particular has not yet been investigated.Methods: A case-control study was conducted in São Paulo, Brazil, with 458 age-matched pairs of Brazilian women. Energy-adjusted intakes of folate, vitamin B6, and vitamin B12were derived from a validated Food Frequency Questionnaire (FFQ). Genotyping was completed forMTHFRA1298C and C677T, andMTRA2756G polymorphisms. A logistical regression model was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs).Results: Neither dietary intake of folate, vitamin B6, or vitamin B12norMTHFRpolymorphisms were independently associated with breast cancer risk. Analysis stratified by menopausal status showed a significant association between placement in the highest tertile of folate intake and risk of breast cancer in premenopausal women (OR = 2.17, 95% CI: 1.23–3.83;Ptrend= 0.010). TheMTR2756GG genotype was associated with a higher risk of breast cancer than the 2756AA genotype (OR = 1.99, 95% CI = 1.01–3.92;Ptrend= 0.801), and statistically significant interactions with regard to risk were observed between theMTHFRA1298C polymorphism and folate (P = 0.024) or vitamin B6(P = 0.043), and between theMTHFRC677T polymorphism and folate (P = 0.043) or vitamin B12(P = 0.022).Conclusion: MTHFRpolymorphisms and dietary intake of folate, vitamin B6, and vitamin B12had no overall association with breast cancer risk. However, increased risk was observed in total women with theMTR2756GG genotype and in premenopausal women with high folate intake. These findings, as well as significant interactions betweenMTHFRpolymorphisms and B vitamins, warrant further investigation.
- 24 April 2009
- Published by Springer Nature in BMC Cancer
- Vol. 9 (1) , 122
Open AccessDietary intake of folate, vitamin B6, and vitamin B12, genetic polymorphism of related enzymes, and risk of breast cancer: a case-control study in Brazilian women
Background: Several studies have determined that dietary intake of B vitamins may be associated with breast cancer risk as a result of interactions between5,10-methylenetetrahydrofolate reductase (MTHFR)andmethionine synthase(MTR) in the one-carbon metabolism pathway. However, the association between B vitamin intake and breast cancer risk in Brazilian women in particular has not yet been investigated.Methods: A case-control study was conducted in São Paulo, Brazil, with 458 age-matched pairs of Brazilian women. Energy-adjusted intakes of folate, vitamin B6, and vitamin B12were derived from a validated Food Frequency Questionnaire (FFQ). Genotyping was completed forMTHFRA1298C and C677T, andMTRA2756G polymorphisms. A logistical regression model was used to calculate odds ratios (ORs) and 95% confidence intervals (95% CIs).Results: Neither dietary intake of folate, vitamin B6, or vitamin B12norMTHFRpolymorphisms were independently associated with breast cancer risk. Analysis stratified by menopausal status showed a significant association between placement in the highest tertile of folate intake and risk of breast cancer in premenopausal women (OR = 2.17, 95% CI: 1.23–3.83;Ptrend= 0.010). TheMTR2756GG genotype was associated with a higher risk of breast cancer than the 2756AA genotype (OR = 1.99, 95% CI = 1.01–3.92;Ptrend= 0.801), and statistically significant interactions with regard to risk were observed between theMTHFRA1298C polymorphism and folate (P = 0.024) or vitamin B6(P = 0.043), and between theMTHFRC677T polymorphism and folate (P = 0.043) or vitamin B12(P = 0.022).Conclusion: MTHFRpolymorphisms and dietary intake of folate, vitamin B6, and vitamin B12had no overall association with breast cancer risk. However, increased risk was observed in total women with theMTR2756GG genotype and in premenopausal women with high folate intake. These findings, as well as significant interactions betweenMTHFRpolymorphisms and B vitamins, warrant further investigation.